Clinical Trials in Chicago

Showing 4061-4080 of 9,860 trials

WITHDRAWNPhase 22.2 miles

Single vs Multi-fraction SRS Patients on Immunotherapy

NCT04427228

This study is meant to compare different surgical approaches to brain cancer.

Brain CancerBrain Metastases

University of ChicagoStarted Jun 2020

Chicago, Illinois, United States

UNKNOWNPhase 12.2 miles

A Dose Finding Study to Treat Bone Tumor(s)

NCT06008483

To determine the Maximum Tolerated Dose (MTD) of CycloSam®, Samarium-153-DOTMP (Sm-153-DOTMP), a radiopharmaceutical that delivers radiation to the bone when injected, given as a tandemly administered pair of doses to subjects with one or more solid tumor(s) in the bone or metastatic solid tumors to the bone that are visible on bone scan.

Bone CancerBone TumorSolid Tumor+2 more

QSAM Therapeutics, Inc.17 participantsStarted Apr 2022

Chicago, Illinois, United States • Columbia, Missouri, United States • New Brunswick, New Jersey, United States +1 more locations

TERMINATEDPhase 32.2 miles

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

NCT01011478

RATIONALE: Rosuvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving rosuvastatin after surgery may kill any tumor cells that remain after surgery. It may also keep polyps from forming or colon cancer from coming back. It is not yet known whether rosuvastatin is more effective than a placebo in treating colon cancer that was removed by surgery. PURPOSE: This randomized phase III trial is studying rosuvastatin to see how well it works compared with placebo in treating patients with stage I or stage II colon cancer that was removed by surgery.

Colorectal CancerPrecancerous Condition

NSABP Foundation Inc406 participantsStarted Mar 2010

Anniston, Alabama, United States • Mobile, Alabama, United States • Fort Smith, Arkansas, United States +584 more locations

Single vs Multi-fraction SRS Patients on Immunotherapy

A Dose Finding Study to Treat Bone Tumor(s)

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Find Trials by Condition in Chicago

Safety and Tolerability of Repeat Courses of IM Alefacept

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Maximizing Outcomes in Treating Acute Migraine

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

Real World Perspectives on Advancements in Hearing Aid Technology

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)

BioVentrix Revivent TC™ System Clinical Study

RObotic Versus LAparoscopic Resection for Rectal Cancer

Study of Sargramostim in Patients With COVID-19

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

Investigation of Novel Surgical Imaging for Tumor Excision

M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer